Graves' Ophthalmopathy Clinical Trial
Official title:
Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies
The purpose of this study is to determine whether radioactive iodine, as compared to anti-thyroid medications, is a risk factor for the development or progression of thyroid-associated ophthalmopathy in patients with hyperthyroidism due to Graves' disease. The other aim of this study is to determine the incidence of the various ophthalmopathy subtypes and the utility of orbital antibodies in the diagnosis, classification and monitoring of patients with thyroid-associated ophthalmopathy.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02059655 -
Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study)
|
Phase 4 | |
| Completed |
NCT02721992 -
Graves' Orbitopathy and Hypercholesterolemia
|
N/A | |
| Recruiting |
NCT02290704 -
Retinal Oxygen Saturation in Patients With Graves' Ophthalmopathy and in Normal People
|
N/A | |
| Recruiting |
NCT01969019 -
A Prospective, Randomized Trial of Intravenous Pulse Versus Sequential Steroid Therapy for Patients With Graves' Orbitopathy
|
Phase 4 | |
| Recruiting |
NCT01056419 -
The Effect of Early Total Thyroidectomy in the Course of Graves' Orbitopathy
|
Phase 4 | |
| Completed |
NCT00697528 -
Color Doppler Imaging of Orbital Venous Flow in Grave's Orbitopathy
|
N/A | |
| Recruiting |
NCT00174057 -
The Role of TSH Receptor, PPAR-r, IGF-1R, IGF and Cytokines in Different Stages of Graves’Ophthalmopathy
|
N/A | |
| Completed |
NCT03922321 -
Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy (GO)
|
Phase 2 |